BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 10614001)

  • 1. Downregulation of MHC class II expression by oxidant-induced apoptosis in EBV-transformed B-cells.
    Park JH; Na SY; Lee YJ; Cho EW; Kim KL
    Mol Cells; 2000 Dec; 10(6):654-61. PubMed ID: 11211870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II transactivator: mastering the art of major histocompatibility complex expression.
    Harton JA; Ting JP
    Mol Cell Biol; 2000 Sep; 20(17):6185-94. PubMed ID: 10938095
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantifying transcription factor binding dynamics at the single-molecule level in live cells.
    Presman DM; Ball DA; Paakinaho V; Grimm JB; Lavis LD; Karpova TS; Hager GL
    Methods; 2017 Jul; 123():76-88. PubMed ID: 28315485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator.
    Voong LN; Slater AR; Kratovac S; Cressman DE
    J Biol Chem; 2008 Apr; 283(14):9031-9. PubMed ID: 18245089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstructing an ancestral mammalian immune supercomplex from a marsupial major histocompatibility complex.
    Belov K; Deakin JE; Papenfuss AT; Baker ML; Melman SD; Siddle HV; Gouin N; Goode DL; Sargeant TJ; Robinson MD; Wakefield MJ; Mahony S; Cross JG; Benos PV; Samollow PB; Speed TP; Graves JA; Miller RD
    PLoS Biol; 2006 Mar; 4(3):e46. PubMed ID: 16435885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases.
    O'Keefe GM; Nguyen VT; Benveniste EN
    J Neurovirol; 2002 Dec; 8(6):496-512. PubMed ID: 12476345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
    Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
    Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.
    Morris AC; Beresford GW; Mooney MR; Boss JM
    Mol Cell Biol; 2002 Jul; 22(13):4781-91. PubMed ID: 12052885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DM can partially replace the invariant chain for HLA-DR transport and surface expression in transfected endocrine epithelial cells.
    Serradell L; Muntasell A; Catálfamo M; Martí M; Costa M; de Préval C; Jaraquemada D
    Tissue Antigens; 1999 May; 53(5):447-58. PubMed ID: 10372540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common set of factors control the expression of the MHC class II, invariant chain, and HLA-DM genes.
    Boss JM
    Microbes Infect; 1999 Sep; 1(11):847-53. PubMed ID: 10614001
    [No Abstract]   [Full Text] [Related]  

  • 11. Class II MHC genes: a model gene regulatory system with great biologic consequences.
    Ting JP; Zhu XS
    Microbes Infect; 1999 Sep; 1(11):855-61. PubMed ID: 10614002
    [No Abstract]   [Full Text] [Related]  

  • 12. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
    Masternak K; Reith W
    EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
    Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
    J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of MHC class II expression.
    Ting JP; Trowsdale J
    Cell; 2002 Apr; 109 Suppl():S21-33. PubMed ID: 11983150
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.